Search Results

The DBB-05 Hemodialysis Delivery System is indicated for hemodialysis prescribed by physicians for adult and pediatric patients with acute or chronic renal failure. The DBB-05 is intended for hemodialysis performed in hospitals and dialysis clinics by a qualified operator.

The DBB-05 Hemodialysis Delivery System is composed of a hydraulic unit for the delivery of dialysate and extracorporeal blood circuitry. The permeate is heated and deaerated in the hydraulic section, which is then mixed with concentrate and fed into the dialyser through the dialysate fluid feeder. The closed balancing system assures the amount of dialysate infused corresponds to the amount of dialysate extracted. The interior pressure of the dialyser is controlled automatically by adjustment of the Ultra Filtration (UF) amount and UF rate by the dialyser. Heparinization of the external circulating blood is performed with the heparin pump either by continuous or one-shot injection before it is passed on to the dialyser. The DBB-05 Hemodialysis Delivery System uses both acetate dialysis and bicarbonate dialysis. Using the various functions of the device, the conductivity and UF profile can be programmed. In addition, DBB-05 Hemodialysis Delivery System incorporates all functions necessary for double-needle dialysis as well as single-needle dialysis treatment. The hydraulic unit is cleaned and disinfected using selectable cleaning programs and is equipped with the necessary protective systems for patient safety and correct operation.

The provided text is a 510(k) summary for the DBB-05 Hemodialysis Delivery System. It describes the device, its intended use, and claims substantial equivalence to a predicate device (the original Nikkiso DBB-05 Hemodialysis Delivery System cleared under K023509).

However, the summary does not contain the detailed information required to fill out the table and answer the specific questions about acceptance criteria and a study proving the device meets those criteria.

Here's why and what information is missing:

• No Acceptance Criteria or Performance Data: The document explicitly states that the device received a 510(k) clearance based on "substantial equivalence" to a predicate device. This means the manufacturer argued the new device is as safe and effective as the previously cleared device, not necessarily that it met new, quantitative acceptance criteria through a specific performance study outlined in the summary.
• No Standalone Study Described: The core argument for clearance is equivalence, not a standalone performance study. While it mentions "verification and validation activities," these are described generally as proving the modified device is substantially equivalent, not as a specific clinical or technical study with defined acceptance criteria and performance results.
• No Information on Test Sets, Ground Truth, Experts, MRMC, or Training: Since a specific performance study proving new acceptance criteria is not described, all related questions about sample sizes, data provenance, number of experts, ground truth, MRMC studies, and training sets are unanswered by the provided text.

In summary, the document states that the device is substantially equivalent to a predicate device, and the modifications do not raise new safety or effectiveness questions. It does not provide data from a study designed to demonstrate performance against specific, quantifiable acceptance criteria.

Therefore, I cannot populate the table or answer the questions as requested based only on the provided text. The missing information would typically be found in a more detailed Device Description, Performance Data, or Clinical Data section of a 510(k) submission, which is not fully included here.

Ask a specific question about this device

The DBB-05 Hemodialysis Delivery System is indicated for hemodialysis prescribed by physicians for adult and pediatric patients with acute or chronic renal failure. The DBB-05 is intended for hemodialysis performed in hospitals and dialysis clinics by a qualified operator.

The subject device is composed of a hydraulic unit for the delivery of dialysate and extracorporeal blood circuitry. The permeate is heated and deaerated in the hydraulic section, which is then mixed with concentrate and fed into the dialyser through the dialysate fluid feeder. The closed balancing system assures the amount of dialysate infused corresponds to the amount of dialysate extracted. The interior pressure of the dialyser is controlled automatically by adjustment of the ultra filtration amount and UF rate by the dialyser. Heparinization of the external circulating blood can be done with the heparin pump either by continuous or one-shot injection before it is passed on to the dialyser. The subject device uses both acetate dialysis and bicarbonate dialysis. Using the various functions the device, the conductivity and UF profile can be programmed. In addition, the subject device incorporates all functions necessary for double-needle dialysis as well as single-needle dialysis treatment. The hydraulic unit is cleaned and disinfected using selectable cleaning programs and is equipped with the necessary protective systems for patient safety and correct operation.

Here's a breakdown of the acceptance criteria and study information based on the provided document:

This document is a 510(k) summary for a medical device (DBB-05 Hemodialysis Delivery System) seeking clearance from the FDA. 510(k) submissions typically show substantial equivalence to a predicate device rather than conducting a full clinical trial to establish new efficacy or safety. Therefore, the "study" described focuses on performance testing to demonstrate that the new device functions as intended and is comparable to existing devices.

1. Table of Acceptance Criteria and Reported Device Performance

Explanation of the "Implied" Acceptance Criteria: The document states, "Examination of device function was performed under conditions similar to those found in normal usage to ensure conformance with product specifications." This implies that the acceptance criteria were the defined product specifications for various functional and safety aspects of the device.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: Not specified in the document. The testing described appears to be bench testing or in-house performance verification rather than a patient-based test set.
• Data Provenance: The testing was conducted by Nikkiso Co., LTD, in Japan (where the manufacturer is located). The data is retrospective in the sense that it was generated prior to the 510(k) submission to demonstrate the device's capabilities.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

Since this was performance testing against product specifications, there wasn't a "ground truth" established by external experts in the clinical sense (e.g., diagnosis by radiologists). Instead, the "ground truth" was the device's engineering and functional specifications. The qualifications of the individuals who performed or validated these tests are not provided, but they would typically be engineers and quality control personnel from the manufacturer.

4. Adjudication Method for the Test Set

Not applicable. There was no clinical test set requiring expert adjudication. The testing involved verifying the device's performance against predefined engineering specifications.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size

No, an MRMC comparative effectiveness study was not performed. This type of study is typically done for diagnostic imaging devices to assess human reader performance with and without AI assistance. This device is a hemodialysis delivery system, not a diagnostic imaging AI. The submission focuses on demonstrating substantial equivalence to a predicate device through functional and safety testing.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

This question is not directly applicable to a hemodialysis delivery system in the context of an AI algorithm. The DBB-05 is a physical medical device. The "software tests" mentioned would relate to the embedded software controlling the device's functions, and its standalone performance would be its ability to execute its programmed operations correctly. This was done as part of the functional and safety testing.

7. The Type of Ground Truth Used

The "ground truth" for this submission was the established product specifications and regulatory standards for electrical safety, failure simulation, software, and general device function under normal usage. The device's performance was measured against these predefined criteria.

8. The Sample Size for the Training Set

Not applicable. This device is not an AI algorithm that undergoes a "training set" in the machine learning sense. It's a hardware device with embedded software.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there was no training set for an AI algorithm.

Ask a specific question about this device